Pharmaceutical Policy
Documents
Citizen Petition from The Doctor Patient Forum
1,494 comments
Net support +41% across analyzed comments
Top issues in comments
- Patient access to pain medication
- Narxcare regulation
- Patient stigmatization and discrimination
Citizen Petition from Alliance to Protect Insulin Choice
41 comments
Net support +78% across analyzed comments
Top issues in comments
- Insulin availability and alternatives
- Basal insulin action profile
- Insulin use in pregnancy
Citizen Petition from Pharmaceutical Safety Oversight Council
6 comments
Net support +100% across analyzed comments
Top issues in comments
- Adverse drug reactions
Citizen Petition from Alliance for Pharmacy Compounding
3 comments
Net support +33% across analyzed comments
Top issues in comments
- Regulatory classification of dte
- Safety and efficacy of dte
Citizen Petition from Evan H. Couture
2 comments
Net support +100% across analyzed comments
Top issues in comments
- Regulatory consistency
- Regulatory parity and consistency
Medicare Program: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
0 comments
Analysis in progress
Top issues in comments
Vanda Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Refuse To Approve a Supplemental New Drug Application for HETLIOZ (Tasimelteon)
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Experience/Events With Approved New Animal Drugs
0 comments
Analysis in progress
Top issues in comments
Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments
0 comments
Analysis in progress
Top issues in comments
Suitability Petition from Felix Pharmaceuticals Pvt. Ltd.
0 comments
Analysis in progress
Top issues in comments
Suitability Petition from Hyman, Phelps, & McNamara P.C.
0 comments
Analysis in progress
Top issues in comments
